BridgeMD
New treatment option for Monkey Pox
Official title Clinical and Biological Aspects of the MONKEYPOX Disease
ClinicalTrials.gov ID: NCT05627713
What this study is testing
- What it's testing
- Monkey pox virus (MPXV), of the genus Orthopoxvirus, regularly causes epidemics in endemic areas of central and western Africa. Since January 1, 2022, cases of Monkey pox have been reported to WHO by 96 Member States in the 6 WHO regions.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Adult,
- eligible for MPXV vaccination according to HAS criteria or suspected of MPXV infection
- whose health status is compatible with a 45 ml single blood sample
- who have consented to participate in the study
- who are covered by a Social Health Insurance plan
You likely can't join if
- Person with MPXV vaccination without proof of vaccination.
- For persons presenting for MPXV vaccination: presence of a contraindication to vaccination other than a current infection.
- Pregnant and lactating women
- Person unable to give informed consent to participate
The study team makes the final eligibility decision.
Where it's taking place
- Paris, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.